The JAZZ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the JAZZ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The JAZZ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View JAZZ Detailed Price Forecast - CNN Money||View JAZZ Detailed Summary - Google Finance|
|View JAZZ Detailed Summary - Yahoo! Finance||View JAZZ Stock Research & Analysis - Zacks.com|
|View JAZZ Trends & Analysis - Trade-Ideas||View JAZZ Major Holders - Barrons|
|View JAZZ Call Transcripts - NASDAQ||View JAZZ Breaking News & Analysis - Seeking Alpha|
|View JAZZ Annual Report - CompanySpotlight.com||View JAZZ OTC Short Report - OTCShortReport.com|
|View JAZZ Fundamentals - TradeKing||View JAZZ SEC Filings - Bar Chart|
|View Historical Prices for JAZZ - The WSJ||View Performance/Total Return for JAZZ - Morningstar|
|View the Analyst Estimates for JAZZ - MarketWatch||View the Earnings History for JAZZ - CNBC|
|View the JAZZ Earnings - StockMarketWatch||View JAZZ Buy or Sell Recommendations - MacroAxis|
|View the JAZZ Bullish Patterns - American Bulls||View JAZZ Short Pain Metrics - ShortPainBot.com|
|View JAZZ Stock Mentions - StockTwits||View JAZZ Stock Mentions - PennyStockTweets|
|View JAZZ Stock Mentions - Twitter||View JAZZ Investment Forum News - Investor Hub|
|View JAZZ Stock Mentions - Yahoo! Message Board||View JAZZ Stock Mentions - Seeking Alpha|
|View Insider Transactions for JAZZ - SECform4.com||View Insider Transactions for JAZZ - Insider Cow|
|View JAZZ Major Holdings Summary - CNBC||View Insider Disclosure for JAZZ - OTC Markets|
|View Insider Transactions for JAZZ - Yahoo! Finance||View Institutional Holdings for JAZZ - NASDAQ|
|View JAZZ Stock Insight & Charts - FinViz.com||View JAZZ Investment Charts - StockCharts.com|
|View JAZZ Stock Overview & Charts - BarChart||View JAZZ User Generated Charts - Trading View|
Free Daily Technical Summary Reports on Iovance Biotherapeutics and Three Other Biotech Stocks
Posted on Wednesday July 18, 2018
LONDON, UK / ACCESSWIRE / July 18, 2018 / If you want a free Stock Review on IOVA sign up now at www.wallstequities.com/registration. Gains were broad based as six out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Biotechnology stocks: GlycoMimetics Inc. (NASDAQ: GLYC), Iovance Biotherapeutics Inc. (NASDAQ: IOVA), Jaguar Health Inc. (NASDAQ: JAGX), and Jazz Pharmaceuticals PLC (NASDAQ: JAZZ).
See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.
Posted on Tuesday July 17, 2018
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
Posted on Friday July 13, 2018
A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a generic version of the medicine. The U.S. Court of Appeals for the Federal Circuit affirmed a series of rulings in favor of Amneal that the Jazz patents described obvious ideas. Shares of Jazz fell 2.5 percent to $175 in morning trading, while Amneal was up 1 percent to $18.50.
Morgan Stanley Downgrades Jazz Pharmaceuticals As Stock Approaches Price Target
Posted on Wednesday July 11, 2018
Morgan Stanley analyst wants to move to the sidelines on Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) as the stock has gained around 34 percent year-to-date and approached his price target of $183. The Analyst ...